Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ganesh Radhakrishna

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
The Lancet. Oncology|March 12, 2013
Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trialSomnath Mukherjee, Christopher N Hurt, John Bridgewater, et al.
BMC Cancer|February 6, 2019
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)Victoria Y Strauss, Rachel Shaw, Pradeep S Virdee, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2017
NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinomaSomnath Mukherjee, Christopher Nicholas Hurt, Sarah Gwynne, et al.
British Journal of Cancer|July 10, 2020
Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus positionChristopher M Jones, Ganesh Radhakrishna, Katharine Aitken, et al.
Translational Oncology|April 29, 2014
Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility StudyAgata I Rembielak, Pooja Jain, Andrew S Jackson, et al.
Contemporary Clinical Trials|June 17, 2026
Ultra-high dose radiation for Liver metastasis using MR-guided TReatment with stereotactic Ablative Single-fraction (ULTRAS): Study protocol for a phase III randomized controlled trialHarroun Wong, Sylvia S W Ng, Issa Mohamad, et al.
BMC Cancer|April 17, 2015
NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinomaSomnath Mukherjee, Christopher N Hurt, Sarah Gwynne, et al.
Current Oncology (Toronto, Ont.)|October 27, 2023
Local Control Following Stereotactic Body Radiation Therapy for Liver Oligometastases: Lessons from a Quarter CenturySara Mheid, Stefan Allen, Sylvia S W Ng, et al.
Eclinicalmedicine|July 6, 2023
Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trialSomnath Mukherjee, Christopher N Hurt, Richard Adams, et al.
European Journal of Cancer (Oxford, England : 1990)|June 22, 2021
Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trialSomnath Mukherjee, Christopher Hurt, Ganesh Radhakrishna, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
The Lancet. Oncology|March 12, 2013
Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trialSomnath Mukherjee, Christopher N Hurt, John Bridgewater, et al.
BMC Cancer|February 6, 2019
Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2)Victoria Y Strauss, Rachel Shaw, Pradeep S Virdee, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2017
NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinomaSomnath Mukherjee, Christopher Nicholas Hurt, Sarah Gwynne, et al.
British Journal of Cancer|July 10, 2020
Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus positionChristopher M Jones, Ganesh Radhakrishna, Katharine Aitken, et al.
Translational Oncology|April 29, 2014
Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility StudyAgata I Rembielak, Pooja Jain, Andrew S Jackson, et al.
Contemporary Clinical Trials|June 17, 2026
Ultra-high dose radiation for Liver metastasis using MR-guided TReatment with stereotactic Ablative Single-fraction (ULTRAS): Study protocol for a phase III randomized controlled trialHarroun Wong, Sylvia S W Ng, Issa Mohamad, et al.
BMC Cancer|April 17, 2015
NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinomaSomnath Mukherjee, Christopher N Hurt, Sarah Gwynne, et al.
Current Oncology (Toronto, Ont.)|October 27, 2023
Local Control Following Stereotactic Body Radiation Therapy for Liver Oligometastases: Lessons from a Quarter CenturySara Mheid, Stefan Allen, Sylvia S W Ng, et al.
Eclinicalmedicine|July 6, 2023
Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trialSomnath Mukherjee, Christopher N Hurt, Richard Adams, et al.
European Journal of Cancer (Oxford, England : 1990)|June 22, 2021
Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trialSomnath Mukherjee, Christopher Hurt, Ganesh Radhakrishna, et al.
Pageof 5